Ionis Pharmaceuticals Retained Earnings (Accumulated Deficit) 2010-2024 | IONS

Ionis Pharmaceuticals retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $-2.145B, a 20.08% increase year-over-year.

  • Ionis Pharmaceuticals retained earnings (accumulated deficit) for 2023 were $-1.796B, a 25.62% increase from 2022.
  • Ionis Pharmaceuticals retained earnings (accumulated deficit) for 2022 were $-1.43B, a 23.25% increase from 2021.
  • Ionis Pharmaceuticals retained earnings (accumulated deficit) for 2021 were $-1.16B, a 2.53% increase from 2020.

Ionis Pharmaceuticals Retained Earnings (Accumulated Deficit) 2010-2024 | IONS

  • Ionis Pharmaceuticals retained earnings (accumulated deficit) for 2023 were $-1.796B, a 25.62% increase from 2022.
  • Ionis Pharmaceuticals retained earnings (accumulated deficit) for 2022 were $-1.43B, a 23.25% increase from 2021.
  • Ionis Pharmaceuticals retained earnings (accumulated deficit) for 2021 were $-1.16B, a 2.53% increase from 2020.